Recent reports have documented elevated NET levels in both patients with IBD and in experimental colitis models, where excessive NETs (marked by increased MPO and CitH3 levels) impair barrier permeability and exacerbate tissue damage.25 The gene discussed is MPO; the disease is inflammatory bowel disease.